Today, Movano Inc. (NASDAQ:MOVE) announced the pricing of its initial public offering of 8,500,000 shares of its common stock at a public offering price of $5.00 per share.
GLOBALFOUNDRIES and Movano Inc. Partner to Advance Needle-Free Continuous Glucose Monitoring Technology
Manufactured on GF’s 22FDX platform, Movano’s radio frequency-enabled solution will help individuals to manage their glucose levels anywhere, anytime
After announcing $10M in bridge funding in July, the company raised an additional $2.5M to progress the development of its wearable non-invasive continuous glucose monitor
Movano Inc. Exits Stealth Mode and Secures $10M in Additional Funding to Transform Glucose Monitoring with Non-Invasive Technology
Company’s needle-free wearable technology will provide painless, real-time glucose readings at the glance of a wrist